Gut Microbiota, Short Chain Fatty Acids, and Adiposity Across The Epidemiological Transition

Status unconfirmed

Conditions studied: Obesity, Diabetes

In brief

The objective of this study is to define associations between gut microbiota, SCFAs and obesity in populations spanning the epidemiologic transition, and explore mechanisms by which these factors may independently and collectively influence the development of obesity. The central hypothesis of this study is that the composition of gut microbiota drives SCFA production which in turn influences obesity risk at the population-level.

Key facts

Study ID

NCT03378765

Run by

Loyola University

People needed

2000

Starts

2018-01-02

Expected to finish

2025-03-01

Last updated by the study team

2024-03-19

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Identify as African American or Black
• Age 18-50

You may not qualify if…

• Pregnancy, nursing, or planning to become pregnant
• Movement disorders or other disability that limits mobility

Where it is running

• Loyola University Chicago — Maywood, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.